HUMA logo

Humacyte (HUMA) Cash From Financing

Annual CFF

$4.51 M
+$5.95 M+411.69%

December 31, 2023


Summary


Performance

HUMA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHUMAcash flowmetrics:

Quarterly CFF

$849.00 K
+$1.32 M+281.80%

September 30, 2024


Summary


Performance

HUMA Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHUMAcash flowmetrics:

TTM CFF

$62.84 M
+$1.61 M+2.63%

September 30, 2024


Summary


Performance

HUMA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHUMAcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HUMA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+411.7%+353.4%+1294.3%
3 y3 years+119.6%+353.4%+1294.3%
5 y5 years+119.6%+353.4%+1294.3%

HUMA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-98.3%+411.7%-98.7%+211.1%-76.5%+4445.9%
5 y5-year-98.3%+411.7%-99.7%+192.7%-76.5%+4445.9%
alltimeall time-98.3%+411.7%-99.7%+192.7%-76.5%+4445.9%

Humacyte Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$849.00 K(-281.8%)
$62.84 M(+2.6%)
Jun 2024
-
-$467.00 K(-100.7%)
$61.23 M(-9.6%)
Mar 2024
-
$62.80 M(<-9900.0%)
$67.71 M(+1402.4%)
Dec 2023
$4.51 M(-411.7%)
-$335.00 K(-56.2%)
$4.51 M(-2.7%)
Sep 2023
-
-$764.00 K(-112.7%)
$4.63 M(-9.3%)
Jun 2023
-
$6.01 M(-1570.7%)
$5.11 M(-466.2%)
Mar 2023
-
-$409.00 K(+92.9%)
-$1.39 M(-3.6%)
Dec 2022
-$1.45 M
-$212.00 K(-26.6%)
-$1.45 M(-127.2%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$289.00 K(-40.3%)
$5.31 M(-97.9%)
Jun 2022
-
-$484.00 K(+5.0%)
$247.68 M(+0.2%)
Mar 2022
-
-$461.00 K(-107.0%)
$247.25 M(-7.4%)
Dec 2021
$266.98 M(>+9900.0%)
$6.55 M(-97.3%)
$266.98 M(+2.5%)
Sep 2021
-
$242.08 M(<-9900.0%)
$260.44 M(+1318.9%)
Jun 2021
-
-$916.00 K(-104.8%)
$18.36 M(-4.8%)
Mar 2021
-
$19.27 M
$19.27 M
Dec 2020
$2.05 M
-
-

FAQ

  • What is Humacyte annual cash flow from financing activities?
  • What is the all time high annual CFF for Humacyte?
  • What is Humacyte annual CFF year-on-year change?
  • What is Humacyte quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Humacyte?
  • What is Humacyte quarterly CFF year-on-year change?
  • What is Humacyte TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Humacyte?
  • What is Humacyte TTM CFF year-on-year change?

What is Humacyte annual cash flow from financing activities?

The current annual CFF of HUMA is $4.51 M

What is the all time high annual CFF for Humacyte?

Humacyte all-time high annual cash flow from financing activities is $266.98 M

What is Humacyte annual CFF year-on-year change?

Over the past year, HUMA annual cash flow from financing activities has changed by +$5.95 M (+411.69%)

What is Humacyte quarterly cash flow from financing activities?

The current quarterly CFF of HUMA is $849.00 K

What is the all time high quarterly CFF for Humacyte?

Humacyte all-time high quarterly cash flow from financing activities is $242.08 M

What is Humacyte quarterly CFF year-on-year change?

Over the past year, HUMA quarterly cash flow from financing activities has changed by +$1.18 M (+353.43%)

What is Humacyte TTM cash flow from financing activities?

The current TTM CFF of HUMA is $62.84 M

What is the all time high TTM CFF for Humacyte?

Humacyte all-time high TTM cash flow from financing activities is $266.98 M

What is Humacyte TTM CFF year-on-year change?

Over the past year, HUMA TTM cash flow from financing activities has changed by +$58.34 M (+1294.32%)